References
- Beran J. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine. Expert Rev Vaccines 2007; 6:891-902; PMID:18377352; https://doi.org/http://dx.doi.org/10.1586/14760584.6.6.891
- World Health Organization, Department of communicable diseases surveillance and response. WHO/CDS/CSR/EDC/2000.7: hepatitis A; 2016. Available at: http://www.who.int/csr/disease/hepatitis/HepatitisA_whocdscsredc2000_7.pdf [Accessed 01/16]
- World Health Organization, Department of communicable diseases surveillance and response. WHO/CDC/CSR/LYO/2002.2: hepatitis B; 2016. Available at: http://www.who.int/csr/disease/hepatitis/HepatitisB_whocdscsrlyo2002_2.pdf [Accessed 01/16]
- Marshall H, Nolan T, Diez Domingo J, Rombo L, Sokal EM, Mares J, Casanovas JM, Kuriyakose S, Leyssen M, Jacquet JM. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1–11 years. Vaccine 2010; 28:4411-5; PMID:20434544; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2010.04.040
- World Health Organization. Expanded Programme on Immunization. Global Advisory Group. Meeting (14th: 1991: Antalya T. Expanded Programme on Immunization: report of the 14th Global Advisory Group, 14-18 October 1991), Antalya, Turkey. 1992. Available at: http://apps.who.int/iris/handle/10665/61561 [Accessed 05/16]
- Zanetti AR, Mariano A, Romano L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366(9494):1379-84; PMID:16226616; https://doi.org/http://dx.doi.org/10.1016/S0140-6736(05)67568-X
- Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27: 6550-7; PMID:19729084; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2009.08.048
- Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis 2009; 200:39-47; PMID:19469708; https://doi.org/http://dx.doi.org/10.1086/599332
- Olivier Van Der Meerena, Ulrich Behreb, Priya Crasta. Immunity to hepatitis B persists in adolescents 15–16 years of age vaccinated in infancy with three doses of hepatitis B vaccine. Vaccine 2016, 34(24):2745-9; PMID:27095043; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2016.04.013
- Behre U, Bleckmann G, Crasta PD, Leyssen M, Messier M, Jacquet JM, Hardt K, et al. Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination. Hum Vacc Immunother 2012; 8(6):813-8; https://doi.org/http://dx.doi.org/10.4161/hv.19898
- Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008; 26:6266-73; PMID:18848855; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2008.09.056
- Ze WY. Practice on planned immunology. In: Diao LD, ed. Planned Immunology. 2nd edition. Shanghai: Science and technology literature press. 2001, 29-65.
- Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30:1312-7; https://doi.org/http://dx.doi.org/10.1002/hep.510300511
- Kato H, Nakata K, Hamasaki K, Hida D, Ishikawa H, Aritomi T, Nakao K, Kato Y, Yano M, Eguchi K. Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction. Vaccine 1999; 18:581-7; https://doi.org/http://dx.doi.org/10.1016/S0264-410X(99)00320-5
- Chathuranga LS, Noordeen F, Abeykoon AM. Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka. Int J Infect Dis 2013; 17:e1078-9; https://doi.org/http://dx.doi.org/10.1016/j.ijid.2013.04.009
- Su FH, Cheng SH, Li CY, Chen JD, Hsiao CY, Chien CC, Yang YC, Hung HH, Chu FY. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. Vaccine 2007; 25:8085-90; PMID:17920732; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2007.09.013
- Zuckerman J. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol 2006; 78(2):169-77; PMID:16372285; https://doi.org/http://dx.doi.org/10.1002/jmv.20524
- Su FH, Cheng SH, Li CY, Chen JD, Hsiao CY, Chien CC, Yang YC, Hung HH, Chu FY. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. Vaccine 2007; 25:8085-90; PMID:17920732; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2007.09.013
- Immunization Practices Advisory Committee. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR Recomm Rep 1991; 40:1-25.
- Yao J, Shan H, Chen Y, Jiang ZG, Dai XW, Ren JJ, Xu KJ, Ruan B, Yang SG, Li Q. The one year effects of three doses of hepatitis B vaccine as booster on anti-HBs-negative children 11-15 y after primary immunization; China, 2009-2011. Hum Vacc Immunother 2015; 11(5):1114-9; PMID:25692413
- Chiara F, Bartolucci GB, Cattai M, Piazza A, Nicolli A, Buja A, Trevisan A, et al. Hepatitis B vaccination of adolescents: Significance of non-protective antibodies. Vaccine 2013, 32(1):62-8; PMID:24188755; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2013.10.074
- Spradling PR, Xing J, Williams R, Masunu-Faleafaga Y, Dulski T, Mahamud A, Drobeniuc J, Teshale EH. Immunity to hepatitis B virus infection two decades after implementation of universal infant hepatitis B vaccination: the association of detectable residual antibody and response to a single hepatitis B vaccine challenge dose. Clin Vaccine Immunol 2013; 20:559-61; PMID:23408522; https://doi.org/http://dx.doi.org/10.1128/CVI.00694-12
- Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, Bruden DL, Nainan OV, Khristova ML, Hennessy TW, et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J 2005; 24:786-92; PMID:16148845; https://doi.org/http://dx.doi.org/10.1097/01.inf.0000176617.63457.9f
- Poorolajal J, Hooshmand E. Booster dose vaccination for preventing hepatitis B. Cochrane Database Syst Rev, 2016; 6:CD008256.
- Kao JT, Wang JH, Hung CH, Yen YH, Hung SF, Hu TH, Lee CM, Lu SN. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan. Vaccine 2009; 27:1858-62; PMID:19186203; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2009.01.027
- Lu JJ, Cheng CC, Chou SM, Hor CB, Yang YC, Wang HL. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan. Vaccine 2009; 27:6613-8; PMID:19698812; https://doi.org/http://dx.doi.org/10.1016/j.vaccine.2009.08.007
- Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, Huang LM, Chen CJ, Chen DS. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 2010; 51:1547-54; PMID:20209603; https://doi.org/http://dx.doi.org/10.1002/hep.23543
- Su FH, Chu FY, Bai CH, Lin YS, Hsueh YM, Sung FC, Yeh CC. Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan. Hepatatology 2010, 51(5):1547-54; https://doi.org/http://dx.doi.org/10.1002/hep.23543
- Alfaleh F, Alshehri S, Alansari S, Aljeri M, Almazrou Y, Sha A, Abdo AA. Long-term protection of hepatitis B vaccine 18 years after vaccination. J Infect. 2008; 57(5):404-9; PMID:18829116; https://doi.org/http://dx.doi.org/10.1016/j.jinf.2008.08.008
- Yoshida T, Saito I. Hepatitis B booster vaccination for healthcare workers. Lancet 2000; 355: 1464; PMID:10791552; https://doi.org/http://dx.doi.org/10.1016/S0140-6736(05)74663-8
- Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, Bruden DL, Nainan OV, Khristova ML, Hennessy TW, et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J 2005; 24:786-92; PMID:16148845; https://doi.org/http://dx.doi.org/10.1097/01.inf.0000176617.63457.9f